In the Original Investigation titled “Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer,”1 published October 7, 2020, there was a numeric error in Table 1. The percentage of female patients given as 56.3 should have been 53.6. This article has been corrected.1
Numeric Error in Table 1. JAMA Netw Open. 2021;4(7):e2123147. doi:10.1001/jamanetworkopen.2021.23147
Customize your JAMA Network experience by selecting one or more topics from the list below.